未找到相关数据
The use of single-agent sorafenib in the treatment of patients with advanced hepatocellular carcinoma with underlying Child-Pugh B liver cirrhosis.
被引：1
作者：
Chiu, J.
Tang, Y. F.
Yao, T. J.
Wong, A.
Wong, H.
Leung, R. C.
Chan, P.
Cheung, T. T.
Poon, R. T. P.
Fan, S. T.
Yau, C. C.
机构：
[1] Dept Med, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Clin Trials Ctr, Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
[4] Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[5] Ruttonjee Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[6] Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China
[7] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China
[8] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China
[9] Univ Hong Kong, Dept Med & Surg, Hong Kong, Hong Kong, Peoples R China
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.4083
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4083
引用
收藏
页数：1
相关论文